Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Paul Ausick | Jan 10, 2019 at 9:10 AM EST

Flu Season Could Cost Employers $17 Billion

The 2018-2019 flu season is predicted to cost U.S. businesses some $17 billion in lost productivity. Here are some steps…

Chris Lange | Jan 9, 2019 at 12:15 PM EST

Why the FDA Is Coming Down on Akorn

Akorn shares dipped on Wednesday after the company received a warning letter from the FDA regarding its Decatur, Illinois, manufacturing…

Chris Lange | Jan 8, 2019 at 12:55 PM EST

Moderna Makes Big Post-IPO Strides With Pipeline Update

Moderna shares made a handy gain early Tuesday after the company announced updates to several of its immuno-oncology and rare…

Chris Lange | Jan 8, 2019 at 8:55 AM EST

Alector Files for IPO

Clinical-stage biopharmaceutical company Alector has filed with the SEC for its initial public offering.

Chris Lange | Jan 7, 2019 at 11:05 AM EST

Are Loxo Shareholders Getting Enough in the Buyout?

Loxo shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli…

Chris Lange | Jan 7, 2019 at 11:00 AM EST

Why Axsome Therapeutics Depression Study Is All Smiles

Axsome shares absolutely exploded on Monday after the company announced that its midstage trial in patients with major depressive disorder…

Chris Lange | Jan 7, 2019 at 10:25 AM EST

Poseida Therapeutics Gears Up for IPO

Clinical-stage biopharmaceutical company Poseida Therapeutics has filed with the SEC regarding its initial public offering.

Chris Lange | Jan 7, 2019 at 8:35 AM EST

Major Biopharma Catalysts Coming in the First Quarter of 2019

Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Jan 4, 2019 at 12:15 PM EST

Ultragenyx Wins Big in Blood Sugar Study

Ultragenyx Pharma shares made a handy gain to close out the week after the company announced positive results from its…

Jon C. Ogg | Jan 4, 2019 at 12:10 PM EST

6 Top Health Care Picks Set to Scream Higher in 2019

A prominent health care analyst has identified his top health care stock picks for 2019, and some are somewhat speculative.

Chris Lange | Jan 4, 2019 at 11:35 AM EST

Will the Selecta Biosciences Restructuring Pay Off?

Selecta Biosciences shares pushed higher on Friday after the company provided an update on its new streamlined structure under its…

Chris Lange | Jan 4, 2019 at 9:50 AM EST

Epizyme Wins FDA Approval and Maybe More for Lymphoma Study

Epizyme shares jumped on Friday after the company announced a set of pipeline updates as well as a key update…

Chris Lange | Jan 4, 2019 at 8:50 AM EST

How Novavax Is Cashing In for Flu Season

Novavax shares jumped early on Friday after the company reported that its midstage flu vaccine had some positive results.

Douglas A. McIntyre | Jan 4, 2019 at 6:25 AM EST

Air Becomes Unbreathable in Delhi, One of World’s Largest Cities

The air quality in one of the world's largest cities became so bad in the past two days that it…

Chris Lange | Jan 3, 2019 at 1:25 PM EST

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen…

1 … 108 109 110 111 112 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Flu Season Could Cost Employers $17 Billion

Why the FDA Is Coming Down on Akorn

Moderna Makes Big Post-IPO Strides With Pipeline Update

Alector Files for IPO

Are Loxo Shareholders Getting Enough in the Buyout?

Why Axsome Therapeutics Depression Study Is All Smiles

Poseida Therapeutics Gears Up for IPO

Major Biopharma Catalysts Coming in the First Quarter of 2019

Ultragenyx Wins Big in Blood Sugar Study

6 Top Health Care Picks Set to Scream Higher in 2019

Will the Selecta Biosciences Restructuring Pay Off?

Epizyme Wins FDA Approval and Maybe More for Lymphoma Study

How Novavax Is Cashing In for Flu Season

Air Becomes Unbreathable in Delhi, One of World’s Largest Cities

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Forget Ford: Buy This Stock Instead as Oil Prices Soar Worldwide

A $1 Million Portfolio That Quietly Pays You $4,600 a Month, No Job Required

Down 30% from Highs, Wall Street Sees 26% Upside for Datadog

"If a 2% Market Move Makes You Question Your Retirement Plan, You Don't Have One"

A $1 Million Portfolio That Quietly Pays You $4,600 a Month, No Job Required

“If a 2% Market Move Makes You Question Your Retirement Plan, You Don’t Have One”

Mastercard Is One Of Our Top Picks After Q1 Beat

Health and Healthcare Articles

All Health and Healthcare Articles

Flu Season Could Cost Employers $17 Billion

Why the FDA Is Coming Down on Akorn

Moderna Makes Big Post-IPO Strides With Pipeline Update

Alector Files for IPO

Are Loxo Shareholders Getting Enough in the Buyout?

Why Axsome Therapeutics Depression Study Is All Smiles

Poseida Therapeutics Gears Up for IPO

Major Biopharma Catalysts Coming in the First Quarter of 2019

Ultragenyx Wins Big in Blood Sugar Study

6 Top Health Care Picks Set to Scream Higher in 2019

Will the Selecta Biosciences Restructuring Pay Off?

Epizyme Wins FDA Approval and Maybe More for Lymphoma Study

How Novavax Is Cashing In for Flu Season

Air Becomes Unbreathable in Delhi, One of World’s Largest Cities

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Forget Ford: Buy This Stock Instead as Oil Prices Soar Worldwide

A $1 Million Portfolio That Quietly Pays You $4,600 a Month, No Job Required

Down 30% from Highs, Wall Street Sees 26% Upside for Datadog

Featured Reads

"If a 2% Market Move Makes You Question Your Retirement Plan, You Don't Have One"

A $1 Million Portfolio That Quietly Pays You $4,600 a Month, No Job Required